Zim Laboratories Limited (ZIMLAB) — Cash Flow-to-Debt Ratio
Zim Laboratories Limited (ZIMLAB) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2023, meaning its operating cash flow of Rs81.71 Million could theoretically repay 0% of its total liabilities (Rs1.40 Billion) in one year. See ZIMLAB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zim Laboratories Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Zim Laboratories Limited across 13 annual periods. Also explore ZIMLAB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zim Laboratories Limited (2013–2025)
Year-by-year debt coverage analysis for Zim Laboratories Limited. For market capitalisation and broader financial context, see ZIMLAB market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Rs411.55 Million | Rs2.20 Billion | ▲ +139.4% |
| 2024 | 0.08x | Rs162.78 Million | Rs2.08 Billion | ▼ -70.6% |
| 2023 | 0.27x | Rs375.19 Million | Rs1.41 Billion | ▼ -10.4% |
| 2022 | 0.30x | Rs492.06 Million | Rs1.66 Billion | ▲ +52.7% |
| 2021 | 0.19x | Rs318.51 Million | Rs1.64 Billion | ▲ +51.9% |
| 2020 | 0.13x | Rs219.15 Million | Rs1.71 Billion | ▼ -35.0% |
| 2019 | 0.20x | Rs348.65 Million | Rs1.77 Billion | ▼ -13.2% |
| 2018 | 0.23x | Rs366.13 Million | Rs1.62 Billion | ▼ -0.6% |
| 2017 | 0.23x | Rs320.71 Million | Rs1.41 Billion | ▲ +63.9% |
| 2016 | 0.14x | Rs219.43 Million | Rs1.58 Billion | ▲ +325.4% |
| 2015 | 0.03x | Rs55.85 Million | Rs1.71 Billion | ▲ +44.0% |
| 2014 | 0.02x | Rs33.48 Million | Rs1.48 Billion | ▲ +110.9% |
| 2013 | -0.21x | Rs-231.81 Million | Rs1.11 Billion | — |